Dr. Mohammad M. Al Madani, MD

Dr. Al Madani practices at Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Al Madani's NPI, 1306009071, was assigned on July 3, 2008. Dr. Al Madani holds Pennsylvania license MD468806.

Dr. Al Madani's primary practice is Jefferson Einstein Philadelphia Hospital, at 5501 Old York Road, Philadelphia, PA 19141 in Philadelphia County. The practice phone is (215) 456-6090.

Dr. Al Madani's primary practice is Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Al Madani is also affiliated with WellSpan Ephrata Community Hospital. The medical group on file is WellSpan Digestive Health. Dmand AI also links Dr. Al Madani to 1 more hospital, 5 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al Madani practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Al Madani's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Al Madani's licenses on file in 4 states: Pennsylvania, Arkansas, Kentucky and Ohio.

CMS data shows 478 Medicare services from Dr. Al Madani across 11 procedure codes in 2024, for 160 Medicare patients. Medicare paid $38,664 for them.

CMS counts 160 Medicare patients who saw Dr. Al Madani in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al Madani's median patient age at 70, with 50% women.

In 2024, Dr. Al Madani wrote 786 Medicare Part D claims for 129 patients. 89% of them were for generic drugs. CMS names the drug for 712 of them, across 22 drugs with 11 or more claims each, at $51,913 in total drug cost. In 2023, CMS named 640 claims across 18 drugs.

Dr. Al Madani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 17 procedures of coronary angioplasty and stenting by Dr. Al Madani, more than 44% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Al Madani in 2022. Dr. Al Madani's most frequent co-authors are Steven J. Baumrucker, MD, Sukhdeep Singh Bhogal, MD and Timir Kumar Paul, MD.

CMS Open Payments shows 396 general payments to Dr. Al Madani from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 61% of the total. Abbott Laboratories paid the most, $3,350.